Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study
Romiplostim was effective in increasing platelet counts regardless of the grade of thrombocytopenia. Romiplostim use for the management of CIT will help in correcting CIT and allow resumption of chemotherapy without recurrence of CIT in most patients undergoing cancer chemotherapy.
Authors
- Vikas Talreja (ORCID: https://orcid.org/0000-0002-1599-3047)
- Priyanka Subhagan
- Sangeeta Khatwani
Institutions
- Alkem (India) (IN)
Publication Details
- Journal
- South Asian Journal of Cancer
- Published
- 2025-06-18
- DOI
- https://doi.org/10.1055/s-0045-1809351
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00